https://www.selleckchem.com/products/XL184.html
Differentiating between enteric infection and relapse of inflammatory bowel disease (IBD) is a common clinical challenge. Few studies have evaluated the impact of multiplex gastrointestinal polymerase chain reaction (GI PCR) pathogen panels on clinical practice compared to stool culture. Our aim was to compare the impact of PCR stool testing to conventional stool testing in outpatients presenting with relapse of IBD. In a retrospective cohort study of outpatients with IBD presenting to NYU Langone Health with flare from September 2015 to
Aimer
Commentaire
Partagez
